Incremental Diagnostic Value and Impact on Patient Management of Somatostatin Receptor Scintigraphy with Indium-111-Pentetreotide in Gastroenteropancreatic Neuroendocrine Tumors | Zendy

Sharjeel Usmani | Zendy; Haider Ali Khan | Zendy; Maha Abdulla | Zendy; Najeeb Ahmed | Zendy; Fawaz abu Huda | Zendy; Fahad Marafi | Zendy; Farida al Kandari | Zendy; Shihab al Mohannadi | Zendy; Naheel al Nafisi | Zendy

Open Access

Incremental Diagnostic Value and Impact on Patient Management of Somatostatin Receptor Scintigraphy with Indium-111-Pentetreotide in Gastroenteropancreatic Neuroendocrine Tumors

Author(s) -

Sharjeel Usmani,

Haider Ali Khan,

Maha Abdulla,

Najeeb Ahmed,

Fawaz abu Huda,

Fahad Marafi,

Farida al Kandari,

Shihab al Mohannadi,

Naheel al Nafisi

Publication year - 2011

Publication title -

medical principles and practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.426

H-Index - 45

eISSN - 1423-0151

pISSN - 1011-7571

DOI - 10.1159/000323762

Subject(s) - medicine , scintigraphy , neuroendocrine tumors , somatostatin receptor , somatostatin , radiology , abdomen , radionuclide therapy , nuclear medicine

To evaluate the efficacy of somatostatin analog scintigraphy with indium-111-pentetreotide and its overall impact on management in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research